Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P0539: Prevalence of QuantiFERON Positivity in Patients with Inflammatory Bowel Disease Eligible for Biological Therapy: Clinical and Demographic AnalysisECCO'25
Year: 2025
Authors: Guinea Lagunes , A.(1)*;Philippe Ponce, M.(1);Contreras Aviles, E.(1);Almeida del Prado, G.(1);López Perez, R.(1);Esquivel Steffanoni, M.(1);Jiménez Bobadilla, B.(2);De Leon Rendon, J.L.(3);
(1)Coloproctology Service of Hospital General de México ´´Dr. Eduardo Liceaga´´, Inflammatory Bowel Disease Clinic, Ciudad de México, Mexico;(2)Coloproctology Service of Hospital General de México ´´Dr. Eduardo Liceaga´´, Coloproctology Service, Ciudad de México, Mexico;(3)Coloproctology Service of Hospital General de México ´´Dr. Eduardo Liceaga´´, Inflammatory Bowel Disease Clinic, Mexico, Mexico;

Vajravelu RK, Osterman MT, Aberra FN, Roy JA, Lichtenstein GR, Mamtani R, Goldberg DS, Lewis JD, Scott FI. Indeterminate QuantiFERON-TB Gold Increases Likelihood of Inflammatory Bowel Disease Treatment Delay and Hospitalization. Inflamm Bowel Dis. 2017 Dec 19;24(1):217-226. doi: 10.1093/ibd/izx019. PMID: 29272482; PMCID: PMC7007987. Lai HC, Chang CH, Cheng KS, Chen TW, Tsai YY, Chou JW. QuantiFERON-TB Gold Test Conversion Is Associated with Active Tuberculosis Development in Inflammatory Bowel Disease Patients Treated with Biological Agents: An Experience of a Medical Center in Taiwan. Gastroenterol Res Pract. 2019 Nov 3;2019:7132875. doi: 10.1155/2019/7132875. PMID: 31781198; PMCID: PMC6875270. Calzada-Hernández J, Anton-López J, Bou-Torrent R, Iglesias-Jiménez E, Ricart-Campos S, Martín de Carpi J; Carmen García de Vicuña Muñoz de la Nava; Torrente-Segarra V, Sánchez-Manubens J, Giménez-Roca C, Rozas-Quesada L, Juncosa-Morros MT, Fortuny C, Noguera-Julian A. Tuberculosis in pediatric patients treated with anti-TNFα drugs: a cohort study. Pediatr Rheumatol Online J. 2015 Dec 3;13:54. doi: 10.1186/s12969-015-0054-4. PMID: 26635208; PMCID: PMC4669612. Calzada-Hernández J, Anton J, Martín de Carpi J, López-Montesinos B, Calvo I, Donat E, Núñez E, Blasco Alonso J, Mellado MJ, Baquero-Artigao F, Leis R, Vegas-Álvarez AM, Medrano San Ildefonso M, Pinedo-Gago MDC, Eizaguirre FJ, Tagarro A, Camacho-Lovillo M, Pérez-Gorricho B, Gavilán-Martín C, Guillén S, Sevilla-Pérez B, Peña-Quintana L, Mesa-Del-Castillo P, Fortuny C, Tebruegge M, Noguera-Julian A. Dual latent tuberculosis screening with tuberculin skin tests and QuantiFERON-TB assays before TNF-α inhibitor initiation in children in Spain. Eur J Pediatr. 2023 Jan;182(1):307-317. doi: 10.1007/s00431-022-04640-3. Epub 2022 Nov 5. PMID: 36335186; PMCID: PMC9829583.

P0540: Assessment of Metabolic-Associated Liver Disease in Patients with Crohn's Disease in Long-Term RemissionECCO'25
Year: 2025
Authors: Amiama Roig, C.(1)*;Cristina, S.F.(2,3);Laura, G.R.(2,3);Jose Luis, R.G.(2,3);Maria, S.A.(2,3);Eduardo, M.A.(2,3);Joaquin, P.C.(2,3);Irene, G.D.(1);Carmen, A.C.(1);Maria Dolores, M.A.(2,3,4);
(1)La Paz University Hospital, Gastroenterology Department, Madrid, Spain;(2)La Paz University Hospital, Inflammatory Bowel Disease Unit- Gastroenterology Department, Madrid, Spain;(3)La Paz University Hospital Research Institute – IdiPAZ, La Paz University Hospital Research Institute – IdiPAZ, Madrid, Spain;(4)Autonomous University of Madrid, Medical School, Madrid, Spain;
P0541: Placebo rates in randomised clinical trials of Ulcerative Colitis: An individual patient data meta-analysisECCO'25
Year: 2025
Authors: Solitano, V.(1,2)*;Hogan, M.(3);Singh, S.(4);Danese, S.(1);Peyrin-Biroulet, L.(5,6,7);Vuyyuru, S.(2,3);MacDonald, J.K.(3);Zou, G.(3,8);Yuan, Y.(9);Sands, B.E.(10);Panaccione, R.(11);Feagan, B.G.(2,3,8);Hanzel, J.(3,12);Sedano, R.(2,3);Dulai, P.(13);Narula, N.(14);Ma, C.(3,11,15);Jairath, V.(2,3,8,9);
(1)IRCCS Ospedale San Raffaele- Università Vita-Salute San Raffaele, Division of Gastroenterology and Gastrointestinal Endoscopy, Milan, Italy;(2)Western University, Department of Medicine- Division of Gastroenterology, London, Canada;(3)Alimentiv Inc., Medical R&D, London, Canada;(4)University of California, Department of Medicine- Division of Gastroenterology, San Diego, United States;(5)Nancy University Hospital, Department of Gastroenterology, Nancy, France;(6)Groupe Hospitalier privé Ambroise Paré – Hartmann, Paris IBD center, Neuilly sur Seine, France;(7)Nancy University Hospital, INFINY Institute, Nancy, France;(8)Western University, Department of Epidemiology and Biostatistics, London, Canada;(9)Lawson Health Research Institute, Department of Medicine, London, Canada;(10)Icahn School of Medicine at Mount Sinai, Dr. Henry D. Janowitz Division of Gastroenterology, New York, United States;(11)University of Calgary, Division of Gastroenterology and Hepatology, Calgary, Canada;(12)University Medical Centre Ljubljana- University of Ljubljana, Department of Gastroenterology, Ljubljana, Slovenia;(13)Northwestern University, Division of Gastroenterology, Chicago, United States;(14)Farncombe Family Digestive Health Research Institute- McMaster University, Department of Medicine- Division of Gastroenterology, Hamilton, Canada;(15)University of Calgary, Department of Community Health Sciences, Calgary, Canada;
P0542: Systematic Liver Biopsies in IBD Surgery: A Unique Insight into Silent Hepatic AbnormalitiesECCO'25
Year: 2025
Authors: Elommal, H.(1)*;Koulali, H.(2);Elmqaddem, O.(2);Zazour, A.(1);ismaili, Z.(2);Kharrasse, G.(2);
(1)Service d’Hépato-gastro-entérologie CHU MOHAMMED VI Oujda- Université Mohammed Premier Oujda- Laboratoire de recherche de maladie de l’appareil digestif LARMAD.MAROC, Service d’Hépato-gastro-entérologie CHU MOHAMMED VI Oujda, Oujda, Morocco;(2)Service d’Hépato-gastro-entérologie CHU MOHAMMED VI Oujda- Université Mohammed Premier Oujda- Laboratoire de recherche de maladie de l’appareil digestif LARMAD.MAROC, Service d’Hépato-gastro-entérologie CHU MOHAMMED VI Oujda- Université Mohammed Premier Oujda, Oujda, Morocco;
P0543: Impact of disease clearance on the disease course in Ulcerative Colitis patients in clinical remission over a ten-year follow-upECCO'25
Year: 2025
Authors: Telli, P.(1)*;Ataş, O.(2);Çelik , A.O.(2);İstemihan, Z.(1);Nuriyev, K.(1);Rustamzada, A.(1);Genç Uluçeçen, S.(1);Dağcı , G.(1);Yağlı , M.A.(1);Gurbanov, A.(1);Ağargün, B.F.(1);Çavuş, B.(1);Çifcibaşı Örmeci , A.(1);Akyüz, F.(1);Demir, K.(1);Beşışık , S.F.(1);Kaymakoğlu , S.(1);
(1)Istanbul University- Istanbul Faculty of Medicine, Gastroenterology and Hepatology, Istanbul, Turkey;(2)Istanbul University- Faculty of Medicine, Internal Medicine, Istanbul, Turkey;

1. Marchal-Bressenot A, Scherl A, Salleron J, Peyrin-Biroulet L. A practical guide to assess the Nancy histological index for UC. Gut. 2016;65(11):1919-1920. 
2. Wang H, Fewings I, Bornman L, Shadbolt B, Fadia M, Subramaniam K. Histologic remission (NANCY Index) is superior to endoscopic mucosal healing in predicting relapse free survival in patients with ulcerative colitis in clinical and endoscopic remission. Journal of Clinical Gastroenterology. 2023;57(5):494-500.

P0544: Long-term evaluation of quality of life in inflammatory bowel diseases: results from a prospective cohort studyECCO'25
Year: 2025
Authors: Marinica, A.(1)*;State, R.M.(1,2);Miron, M.(1);Mateescu, R.B.(1,2);
(1)Colentina Clinical Hospital, Gastroenterology, Bucharest, Romania;(2)University of Medicine and Pharmacy Carol Davila, Gastroenterology, Bucharest, Romania;

[1]Jowett SL, Seal CJ, Barton JR, Welfare MR. The short inflammatory bowel disease questionnaire is reliable and responsive to clinically important change in ulcerative colitis. Am J Gastroenterol. 2001;96(10):2921-2928. doi:10.1111/j.1572-0241.2001.04682.x

P0545: Risk of rapidly progressive disease course in patients with pediatric-onset ulcerative colitisECCO'25
Year: 2025
Authors: D'Arcangelo, G.(1)*;Raso, T.(1);Ammattatelli, F.(1);Distante, M.(1);Zucconi, F.(1);Rotulo, S.(1);Aloi, M.(1);
(1)Sapienza University of Rome, Department of Pediatrics, Rome, Italy;
  1. 1.      Parigi TL, D'Amico F, Abreu MT, Dignass A, Dotan I, Magro F, Griffiths AM, Jairath V, Iacucci M, Mantzaris GJ, O'Morain C, Reinisch W, Sachar DB, Turner D, Yamamoto T, Rubin DT, Peyrin-Biroulet L, Ghosh S, Danese S. Difficult-to-treat inflammatory bowel disease: results from an international consensus meeting. Lancet Gastroenterol Hepatol. 2023 Sep;8(9):853-859.
P0546: Surgical recurrence following repeated ileocolic resection for Crohn’s disease: a retrospective single center cohort studyECCO'25
Year: 2025
Authors: Haanappel, A.(1)*;Moojen, T.(1);Vlug, M.(1);Hompes, R.(1);Buskens, C.(1);Bemelman, W.(1);
(1)Amsterdam UMC, Surgery, Amsterdam, The Netherlands;

1. Beelen EMJ, van der Woude CJ, Pierik MJ, Hoentjen F, de Boer NK, Oldenburg B, et al. Decreasing Trends in Intestinal Resection and Re-Resection in Crohn's Disease: A Nationwide Cohort Study. Ann Surg. 2021;273(3):557-63.

P0547: Use of MUC score in the activity evaLuation by Pediatric intestinal ultrasound and their corrElation with other clinical and ultrasounD scores (ULPED)ECCO'25
Year: 2025
Authors: Parra Izquierdo, V.(1,2,3)*;Ernest Suarez , K.(4);Argollo, M.(5);Frías-Ordoñez, J.(6)*;Orduz, G.(7);Cubillos, S.(8);Vargas, M.(9);Verstockt, B.(2,3);
(1)Hospital Internacional de Colombia, Gastroenterology and Rheumatology, Bucaramanga, Colombia;(2)KU Leuven Department of Chronic Diseases and Metabolism- Translational Research Center for Gastrointestinal Disorders TARGID, Department of Chronic Diseases and Metabolism, Leuven, Belgium;(3)University Hospitals Leuven- Department of Gastroenterology and Hepatology- KU Leuven, Gastroenterology, Leuven, Belgium;(4)School of Medicine- University of Costa Rica, Gastroenterology, San Jose, Costa Rica;(5)Universidade Federal de São Paulo, Gastroenterology, Sao Paulo, Brazil;(6)National University of Colombia, Gastroenterology, Bogotá, Colombia;(7)Hospital Internacional de Colombia, Center of Excellence in IBD, Bucaramanga, Colombia;(8)Hospital Internacional de Colombia, Radiology, Bucaramanga, Colombia;(9)Gastrokids SAS, Pediatric Gastroenterology, Pereira, Colombia;
P0548: Comparison of C-reactive protein level and intestinal ultrasonography in Crohn's Disease activationECCO'25
Year: 2025
Authors: Yorulmaz, E.(1)*;Yigit, B.(2);Sezgin, O.(3);Erturk, M.S.(4);Yanc, U.(4);Erdem, U.(4);Yorulmaz, H.(5);Bilik Oyman, G.(6);
(1)Bagcilar Education and Research Hospital, Gastroenterology, Istanbul, Turkey;(2)Bagcilar Education and Research Hospital, İnternal Medicine, Istanbul, Turkey;(3)Faculty of Medicine- Mersin University, Gastroenterology, Mersin, Turkey;(4)Sisli Education and Research Hospital, Radiology, Istanbul, Turkey;(5)Halic University, School of Nursing, Istanbul, Turkey;(6)Okmeydani Education and Research Hospital, Internal Medicine, Istanbul, Turkey;

1) Haber HP, Busch A, Ziebach R, Stern M. Bowel wall thickness measured by ultrasound as a marker of Crohn's disease activity in children. The Lancet. 2000;355(9211):1239-40.
2) Kucharzik T, Wittig BM, Helwig U, Börner N, Rössler A, Rath S, et al. Use of intestinal ultrasound to monitor Crohn’s disease activity. Clinical Gastroenterology and Hepatology. 2017;15(4):535-42. e2.
3) Filik L, Dagli U, Ulker A. C-reactive protein and monitoring the activity of Crohn’s disease. Advances in therapy. 2006;23(4):655-62.

P0549: Colombian Observer Inter-agreement in intestinal Ultrasound for ulcerative Colitis (COI-UC)ECCO'25
Year: 2025
Authors: Parra Izquierdo, L.V.(1,2,3)*;Ernest Suárez, K.(4);Argollo, M.(5);Frías-Ordoñez, J.(6);Orduz, G.(7);Ibañez, E.(8);Vargas, M.(9);Cubillos, S.(10);Verstockt, B.(1,3);
(1)University Hospitals Leuven- Department of Gastroenterology and Hepatology- KU Leuven, Gastroenterology, Leuven, Belgium;(2)Hospital Internacional de Colombia, Gastroenterology and Rheumatology, Bucaramanga, Colombia;(3)KU Leuven Department of Chronic Diseases and Metabolism- Translational Research Center for Gastrointestinal Disorders TARGID, Department of Chronic Diseases and Metabolism, Leuven, Belgium;(4)School of Medicine- University of Costa Rica, Gastroenterology, San Jose, Costa Rica;(5)Universidade Federal de São Paulo, Gastroenterology, Sao Paulo, Brazil;(6)National University of Colombia, Gastroenterology, Bogotá, Colombia;(7)Hospital Internacional de Colombia, Center of Excellence in IBD, Bucaramanga, Colombia;(8)El Bosque University, Faculty of Medicine, Bogota, Colombia;(9)Gastrokids SAS, Pediatric Gastroenterology, Pereira, Colombia;(10)Hospital Internacional de Colombia, Radiology, Bucaramanga, Colombia;
P0550: Introducing Intestinal ultrasound in the UK NHS – the first 6-monthsECCO'25
Year: 2025
Authors: Ali, N.(1);Flower, A.(1);McCoubrie, P.(1);Gupta, V.(2);Griffiths, L.(2);Murray, S.(2);Meade, S.(2)*;
(1)North Bristol NHS Trust, Radiology, Bristol, United Kingdom;(2)North Bristol NHS Trust, Gastroenterology, Bristol, United Kingdom;

Taylor SA, Mallett S, Bhatnagar G, et al. Diagnostic accuracy of magnetic resonance enterography and small bowel ultrasound for the extent and activity of newly diagnosed and relapsed Crohn's disease (METRIC): a multicentre trial. Lancet Gastroenterol Hepatol 2018;3(8):548-558. (In eng). DOI: 10.1016/s2468-1253(18)30161-4.

P0551: Diagnostic Accuracy of Low-Cost Blood Test Inflammatory Markers in Severe Ulcerative ColitisECCO'25
Year: 2025
Authors: Sadek, A.(1);Salim, A.(2);Afifi, A.(1)*;Ibrahim , N.(1);Salem , S.(1);
(1)Zagazig University, Internal Medicine, Zagazig, Egypt;(2)Tripoli University, Internal Medicine, Tripoli, Libya;
P0552: Incisional and parastomal hernia after surgical management of inflammatory colitis: a common complication presenting a real therapeutical challenge in a tertiary expert centerECCO'25
Year: 2025
Authors: Océane, L.(1)*;Abdalla, S.(1);Meyer, A.(2);Amiot, A.(2);Carbonnel, F.(2);Penna, C.(1);Benoist, S.(1);Brouquet, A.(1);
(1)Bicêtre Hospital- Assistance Publique – Hôpitaux de Paris- Paris-Saclay University, Department of oncologic and digestive surgery, Le Kremlin-Bicêtre, France;(2)Bicêtre Hospital- Assistance Publique – Hôpitaux de Paris- Paris-Saclay University, Department of gastroenterology, Le Kremlin-Bicêtre, France;

None

P0553: MRI neurophenotype reflecting brain-gut interactions to predict intestinal disease progression in patients with Crohn’s diseaseECCO'25
Year: 2025
Authors: Zhang, R.(1)*;Shen, X.(2);Huang, L.(2);Feng, S.T.(2);Mao, R.(3);Li, X.(2);
(1)The First Affiliated Hospital- Sun Yat-Sen University, Department of Radiology, Guangzhou, China;(2)The First Affiliated Hospital- Sun Yat-Sen University, Radiology, Guangzhou, China;(3)The First Affiliated Hospital- Sun Yat-Sen University, Gastroenterology, Guangzhou, China;

N/A

P0554: Machine Learning-Based Interpretation of Unstructured Radiology Reports for Objective Scoring of Inflammation and Stenosis in IBD: A Nationwide Study From the epi-IIRNECCO'25
Year: 2025
Authors: Badash , Z.(1)*;Gavrielov , N.(2);Hagopian , T.(3);Cytter Kuint , R.(3);Dotan , I.(4);Loewenberg Weisband , Y.(5);Ben-Tov , A.(6);Zacay , G.(7);Matz , E.(8);Focht , G.(9);Turner , D.(9);Freiman , M.(2);
(1)Technion - Israel Institute of Technology, Faculty of data and decision sciences, Haifa, Israel;(2)Technion - Israel Institute of Technology, Faculty of Biomedical Engineering, Haifa, Israel;(3)Shaare Zedek Medical Center, Department of Radiology, Jerusalem, Israel;(4)Rabin Medical Center, Division of Gastroenterology, Petah Tikva, Israel;(5)Clalit Research Institute, Innovation Division, Tel Aviv, Israel;(6)Maccabi Health Services, Medical Informatics, Tel Aviv, Israel;(7)Meuhedet Health Services, Research institute, Tel Aviv, Israel;(8)Leumit Health Services, Gastroenterology, Tel Aviv, Israel;(9)Shaare Zedek Medical Center, The Juliet Keidan Institute of Pediatric Gastroenterology, Jerusalem, Israel; epi-IIRN study group
P0555: Quantitative Assessment of Colon Motility in Ulcerative Colitis using Magnetic Resonance Enterography: Correlation with Endoscopic Disease ActivityECCO'25
Year: 2025
Authors: Sarikhani, M.(1)*;Naim, I.(2);Torabi, A.(1);Amouei, M.(1);Vahedi, H.(3);Sima, A.R.(4);Kolahdoozan, S.(3);Menys, A.(2);Radmard, A.R.(1);
(1)Shariati Hospital- Tehran University of Medical Sciences, Department of Radiology, Tehran, Iran- Islamic Republic Of;(2)Motilent, Motilent, London, United Kingdom;(3)Tehran University of Medical Sciences, Digestive Diseases Research Institute, Tehran, Iran- Islamic Republic Of;(4)Masoud Gastroenterology and Hepatology Center, Sasan Alborz Biomedical Research Center, Tehran, Iran- Islamic Republic Of;
P0556: A novel switching of artificial intelligence to generate simultaneously multimodal images to assess inflammation and predict outcomes in Ulcerative ColitisECCO'25
Year: 2025
Authors: Iacucci, M.(1,2)*;Zammarchi, I.(1);Santacroce, G.(1);Kolawole, B.B.(3);Chaudhari, U.(3);Del Amor, R.(4);Meseguer, P.(4,5);Naranjo, V.(4);Puga-Tejada, M.(1);Capobianco, I.(1);Ditonno, I.(1);Buda, A.(6);Hayes, B.(7);Crotty, R.(7);Bisschops, R.(8);Ghosh, S.(1);Grisan, E.(3);
(1)University College Cork, APC Microbiome Ireland- College of Medicine and Health, Cork, Ireland;(2)Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom;(3)London South Bank University, School of Engineering Computer Science and Informatics, London, United Kingdom;(4)Universitat Politècnica de València, Instituto Universitario de Investigación e Innovación en Tecnología Centarada en el Ser Humano- HUMAN-tech, Valencia, Spain;(5)Universitat Politècnica de València, valgrAI - Valencian Graduate School and Research Network of Artificial Intelligence, Valencia, Spain;(6)Santa Maria del Prato Hospital, Department of Gastrointestinal Oncological Surgery, Feltre, Italy;(7)Cork University Hospital, Department of Histopathology, Cork, Ireland;(8)University Hospitals Leuven, Division of Gastroenterology, Leuven, Belgium; PICaSSO group
P0557: Multiomics analysis identifies key pathways associated with severe disease course in children with IBD: a prospective studyECCO'25
Year: 2025
Authors: Azulay , A.(1)*;Talmor , Y.(2);Borenstein , E.(2,3,4);Focht , G.(1);Maslov , T.(1);Yogev , D.(1);Ledder , O.(1);Lev-Tzion , R.(1);Orlanski Meyer , E.(1);Assa , A.(1);Turner , D.(1);
(1)Juliet Keidan Institute of Pediatric Gastroenterology- Hepatology- and Nutrition- Shaare Zedek Medical Center- Jerusalem- Israel- The Hebrew University of Jerusalem- Israel., Juliet Keidan Institute of Pediatric Gastroenterology- Hepatology- and Nutrition- Shaare Zedek Medical Center- Jerusalem- Israel- The Hebrew University of Jerusalem- Israel., Jerusalem, Israel;(2)School of Computer Science- Tel Aviv University- Tel Aviv- Israel, School of Computer Science- Tel Aviv University- Tel Aviv- Israel, Tel Aviv, Israel;(3)Faculty of Medicine- Tel Aviv University- Tel Aviv- Israel, Faculty of Medicine- Tel Aviv University- Tel Aviv- Israel, Tel Aviv, Israel;(4)Santa Fe Institute- Santa Fe- NM- United States, Santa Fe Institute- Santa Fe- NM- United States, Santa Fe, United States;
P0558: An Integrative Blood-Based Risk Score Predicts Development of Crohn's DiseaseECCO'25
Year: 2025
Authors: Ungaro, R.(1)*;Rajauria, P.(1);Torres, J.(2);Porter, C.(3);Magee, J.(4);Agrawal, M.(1);Dervieux, T.(5);Gnjatic, S.(6);Colombel, J.F.(1);Petralia, F.(7);
(1)Icahn School of Medicine at Mount Sinai, The Henry D. Janowitz Division of Gastroenterology, New York- New York, United States;(2)Hospital Beatriz Ângelo, Division of Gastroenterology, Loures, Portugal;(3)Naval Medical Research Command, Translational and Clinical Research Department, Bethesda- Maryland, United States;(4)Walter Reed National Military Medical Center, Gastroenterology, Bethesda- Maryland, United States;(5)Prometheus Laboratories, Prometheus Laboratories, San Diego- California, United States;(6)Icahn School of Medicine at Mount Sinai, Precision Immunology Institute, New York- New York, United States;(7)Icahn School of Medicine at Mount Sinai, Department of Genetics and Genomic Sciences, New York- New York, United States;